Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09NBM
|
||||
Former ID |
DIB007427
|
||||
Drug Name |
SB-435495
|
||||
Indication | Arteriosclerosis [ICD9: 440; ICD10:I70] | Discontinued in Phase 1 | [1] | ||
Company |
GlaxoSmithKline plc
|
||||
Structure |
![]() |
Download2D MOL |
|||
Canonical SMILES |
n1(c(nc(=O)c(c1)Cc1cnn(c1)C)SCc1ccc(cc1)F)CC(=O)N(Cc1cc<br />c(cc1)c1ccc(cc1)C(F)(F)F)CCN(CC)CC
|
||||
Target and Pathway | |||||
Target(s) | Phospholipase A2 | Target Info | Inhibitor | [2] | |
BioCyc Pathway | Phospholipases | ||||
KEGG Pathway | Glycerophospholipid metabolism | ||||
Ether lipid metabolism | |||||
Arachidonic acid metabolism | |||||
Linoleic acid metabolism | |||||
alpha-Linolenic acid metabolism | |||||
Metabolic pathways | |||||
Ras signaling pathway | |||||
Vascular smooth muscle contraction | |||||
Pancreatic secretion | |||||
Fat digestion and absorption | |||||
Pathway Interaction Database | Fc-epsilon receptor I signaling in mast cells | ||||
Reactome | Acyl chain remodelling of PC | ||||
Acyl chain remodelling of PE | |||||
Acyl chain remodelling of PI | |||||
WikiPathways | Glycerophospholipid biosynthesis | ||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015443) | ||||
REF 2 | The effect of lipoprotein-associated phospholipase A2 deficiency on pulmonary allergic responses in Aspergillus fumigatus sensitized mice. Respir Res. 2012 Nov 12;13:100. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.